Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Randomized, Controlled, Open-Label Study to Evaluate the Safety of Xolair in Moderate to Severe Persistent Asthma Subjects Already Treated With Other Therapies (ALTO)

NCT00401596 is registered in ClinicalTrials.gov with Genentech, Inc. as lead sponsor.

NCT NCT00401596
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00401596 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Randomized, Controlled, Open-Label Study to Evaluate the Safety of Xolair in Moderate to Severe Persistent Asthma Subjects Already Treated With Other Therapies (ALTO)
Lead sponsor
Genentech, Inc.
Phase
Phase 3
Overall status
Completed
Start date
July 31, 2000
Completion date
July 31, 2002
Enrollment
1,899
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

asthma